The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant interest within the British Isles, prompting a notable shift in medication trends. Obtaining these treatments remains a complex landscape, with National Health Service coverage currently limited and independent providers offering treatment at a pre